---
figid: PMC5957297__nihms961982f4
figtitle: MAPK pathway bypass in melanoma
organisms:
- NA
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC5957297
filename: nihms961982f4.jpg
figlink: /pmc/articles/PMC5957297/figure/F4/
number: F4
caption: Pathway bypass confers drug resistance by recruiting alternate effector pathways
  to sustain the index downstream oncogenic output (for example, transcriptional or
  translational state). In BRAF-mutant melanoma, pathway bypass mechanisms reactivate
  the core MITF transcriptional output in a manner that is independent of upstream
  MAPK input. For example, a GPCR-cAMP-CREB signaling axis can substitute for MAPK
  signaling to sustain an MITF-driven transcriptional program. Likewise, MITF amplification
  can render MITF itself independent of MAPK signaling.In prostate cancer, signaling
  through the glucocorticoid receptor (GR) drives a transcriptional program similar
  to that of the index AR signaling pathway, rendering cells resistant to inhibition
  of the AR axis.
papertitle: A convergence-based framework for cancer drug resistance.
reftext: David J. Konieczkowski, et al. Cancer Cell. ;33(5):801-815.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8698019
figid_alias: PMC5957297__F4
figtype: Figure
redirect_from: /figures/PMC5957297__F4
ndex: 09548ff3-df17-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5957297__nihms961982f4.html
  '@type': Dataset
  description: Pathway bypass confers drug resistance by recruiting alternate effector
    pathways to sustain the index downstream oncogenic output (for example, transcriptional
    or translational state). In BRAF-mutant melanoma, pathway bypass mechanisms reactivate
    the core MITF transcriptional output in a manner that is independent of upstream
    MAPK input. For example, a GPCR-cAMP-CREB signaling axis can substitute for MAPK
    signaling to sustain an MITF-driven transcriptional program. Likewise, MITF amplification
    can render MITF itself independent of MAPK signaling.In prostate cancer, signaling
    through the glucocorticoid receptor (GR) drives a transcriptional program similar
    to that of the index AR signaling pathway, rendering cells resistant to inhibition
    of the AR axis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BRAF
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - EPHB2
  - MAPK1
  - MAPK3
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - MITF
  - AR
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - Oamb
  - Erk7
  - rl
  - CrebB
  - CrebA
  - Mitf
  - ar
  - gr
  - Dsor1
  - Mtk
  - androgen
---
